159 related articles for article (PubMed ID: 31409077)
1. Risks of Solid Tumors in Heterozygous Carriers of Recessive Syndromes.
Koudová M; Puchmajerová A
Klin Onkol; 2019; 32(Supplementum2):14-23. PubMed ID: 31409077
[TBL] [Abstract][Full Text] [Related]
2. Genetic Causes of Rare Pediatric Ovarian Tumors.
Plevová P; Geržová H
Klin Onkol; 2019; 32(Supplementum2):79-91. PubMed ID: 31409083
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.
Foretová L; Navrátilová M; Svoboda M; Vašíčková P; Sťahlová EH; Házová J; Kleiblová P; Kleibl Z; Macháčková E; Palácová M; Petráková K
Klin Onkol; 2019; 32(Supplementum2):6-13. PubMed ID: 31409076
[TBL] [Abstract][Full Text] [Related]
4. An Update on Inherited Colon Cancer and Gastrointestinal Polyposis.
Plevová P
Klin Onkol; 2019; 32(Supplementum2):97-108. PubMed ID: 31409085
[TBL] [Abstract][Full Text] [Related]
5. DICER1 Syndrome.
Hořínová V; Drábová K; Nosková H; Bajčiová V; Šoukalová J; Černá L; Hůrková V; Slabý O; Štěrba J
Klin Onkol; 2019; 32(Supplementum2):123-127. PubMed ID: 31409088
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal Polyposes and Lynch Syndrome - a Pathologists Perspective.
Pokorová Š; Fabian P
Klin Onkol; 2019; 32(Supplementum2):92-96. PubMed ID: 31409084
[TBL] [Abstract][Full Text] [Related]
7. Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome.
Pavelka Z; Zitterbart K; Nosková H; Bajčiová V; Slabý O; Štěrba J
Klin Onkol; 2019; 32(1):70-74. PubMed ID: 30764633
[TBL] [Abstract][Full Text] [Related]
8. Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
Neben CL; Zimmer AD; Stedden W; van den Akker J; O'Connor R; Chan RC; Chen E; Tan Z; Leon A; Ji J; Topper S; Zhou AY
J Mol Diagn; 2019 Jul; 21(4):646-657. PubMed ID: 31201024
[TBL] [Abstract][Full Text] [Related]
9. Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.
Kleiblová P; Stolařová L; Křížová K; Lhota F; Hojný J; Zemánková P; Havránek O; Vočka M; Černá M; Lhotová K; Borecká M; Janatová M; Soukupová J; Ševčík J; Zimovjanová M; Kotlas J; Panczak A; Veselá K; Červenková J; Schneiderová M; Burócziová M; Burdová K; Stránecký V; Foretová L; Macháčková E; Tavandzis S; Kmoch S; Macůrek L; Kleibl Z
Klin Onkol; 2019; 32(Supplementum2):36-50. PubMed ID: 31409080
[TBL] [Abstract][Full Text] [Related]
10. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
12. Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.
Soukupová J; Lhotová K; Zemánková P; Vočka M; Janatová M; Stolařová L; Borecká M; Kleiblová P; Macháčková E; Foretová L; Koudová M; Lhota F; Tavandzis S; Zikán M; Stránecký V; Veselá K; Panczak A; Kotlas J; Kleibl Z
Klin Onkol; 2019; 32(Supplementum2):72-78. PubMed ID: 31409082
[TBL] [Abstract][Full Text] [Related]
13. [Recommended Extension of Indication Criteria for Genetic Testing of BRCA1 and BRCA2 Mutations in Hereditary Breast and Ovarian Cancer Syndrome].
Foretová L; Macháčková E; Palácová M; Navrátilová M; Svoboda M; Petráková K
Klin Onkol; 2016; 29 Suppl 1():S9-13. PubMed ID: 26691937
[TBL] [Abstract][Full Text] [Related]
14. Genetic Counselors' Experiences Regarding Communication of Reproductive Risks with Autosomal Recessive Conditions found on Cancer Panels.
Mets S; Tryon R; Veach PM; Zierhut HA
J Genet Couns; 2016 Apr; 25(2):359-72. PubMed ID: 26454646
[TBL] [Abstract][Full Text] [Related]
15. Rare Hereditary Burden associated with a Hypercalcemic Small-Cell Carcinoma of Cervix in a Young Female Patient.
Hruška L; Sirák I; Laco J; Fridrichová P; Nosková H; Slabý O; Pál K; Bočkayová V; Hodek M; Petera J
Klin Onkol; 2019; 32(6):456-462. PubMed ID: 31842565
[TBL] [Abstract][Full Text] [Related]
16. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous manifestations in four autosomal recessive human cancer-prone syndromes: ataxia telangiectasia, xeroderma pigmentosum, Fanconi anemia, and Bloom syndrome.
Heim RA; Lench NJ; Swift M
Mutat Res; 1992 Dec; 284(1):25-36. PubMed ID: 1279391
[No Abstract] [Full Text] [Related]
18. Multigene Testing for Hereditary Cancer: When, Why, and How.
Offit K
J Natl Compr Canc Netw; 2017 May; 15(5S):741-743. PubMed ID: 28515260
[TBL] [Abstract][Full Text] [Related]
19. Hereditary cancer predisposition syndromes.
Garber JE; Offit K
J Clin Oncol; 2005 Jan; 23(2):276-92. PubMed ID: 15637391
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
